Breast cancer drug rejected for Scotland
A DRUG proved to shrink breast cancer tumours before women undergo surgery has been rejected for use on the NHS in Scotland.
Last year, a small study in the US showed that lapatinib (Tyverb) shrank tumours by an average of more than 60 per cent before women had surgery.
The Scottish Medicines Consortium has now assessed the drug, in combination with another treatment, capecitabine, for use in patients with advanced cancer or where the disease has spread, but did not recommend it for use by the NHS.
The SMC said: "The manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC."
Dr Alexis Willett, policy manager at Breakthrough Breast Cancer, said: "(We hope] the SMC and the makers of lapatinib will work together to ensure that if further information becomes available a new appraisal is undertaken swiftly."
Email to a friend
Print this page- Family mourn death of Glasgow ‘fight’ schoolboy
- Rangers takeover: Duff & Phelps threaten legal action against BBC
- Today’s youth not fit to be employed, says car firm Arnold Clark
- Rangers administration: Fans fear Duff & Phelps claims could scare off Green
- Rangers takeover: triple penalty punishment enough, says Johnston
- Alistair Darling leads ‘No to independence’ fight over tea and biscuits
- Scottish independence: SNP flip-flops over Nato
- Scottish Independence: SNP ‘won’t be Yes campaign’s only voice’
- Today’s youth not fit to be employed, says car firm Arnold Clark
- Scottish independence: ‘People here are best qualified to run Scotland’
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Saturday 26 May 2012
Today
Sunny
Temperature: 8 C to 21 C
Wind Speed: 20 mph
Wind direction: North east
Tomorrow
Sunny
Temperature: 11 C to 21 C
Wind Speed: 12 mph
Wind direction: North east
